Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
ADEM Following Malaria.
Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study.
Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Promoting physical activity to control multiple sclerosis from childhood.
Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination.
The use of Doppler ultrasound in the diagnosis of chronic cerebrospinal venous insufficiency.
Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients.
Characterization of Axonal Disease in Patients with Multiple Sclerosis Using High-Gradient-Diffusion MR Imaging.
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial.
A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation.
One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.
Raltegravir with optimized background therapy for resistant HIV-1 infection.
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial.
A salty taste to autoimmunity.
Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.
Hypoxia Inducible Factor-1α in Astrocytes and/or Myeloid Cells Is Not Required for the Development of Autoimmune Demyelinating Disease(,.)
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
The potential of microRNAs as biofluid markers of neurodegenerative diseases - a systematic review.
MRI unsampling using feature-based non-local means approach.
Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
Street-experienced peripheral B cells traffic to the brain.
Clinical trials to clinical use: using vision as a model for multiple sclerosis and beyond.
Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form.
CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis.
Pages
« first
‹ previous
…
265
266
267
268
269
270
271
272
273
…
next ›
last »